Skip to content
Disclosery

Vantage Consulting Group Inc

Follow

13F filer, CIK 1843547, VIRGINIA BEACH, VA

Vantage Consulting Group Inc reported $5,733,711 across 3 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001843547-25-000009

Period
2025-06-30
Reported value
$5.73M
Holdings
3
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ADCTreduced-167,739-$450K
FIBROGEN INCexited-195,707-$60.6K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001843547-25-000009, largest first. % of portfolio is the value over $5,733,711, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BWBABCOCK & WILCOX ENTERPRISESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,416,200 shares; 2024Q2: 2,416,200 shares; 2024Q3: 2,416,200 shares; 2024Q4: 2,416,200 shares; 2025Q1: 2,416,200 shares; 2025Q2: 2,416,200 shares 2,416,200$2.32M40.54%0Timeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 850,737 shares; 2024Q2: 850,737 shares; 2024Q3: 850,737 shares; 2024Q4: 850,737 shares; 2025Q1: 850,737 shares; 2025Q2: 682,998 shares 682,998$1.83M31.92%-167,739Timeline
CBUSCIBUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,143,949 shares; 2024Q2: 1,143,949 shares; 2024Q3: 1,143,949 shares; 2024Q4: 1,143,949 shares; 2025Q1: 1,143,949 shares; 2025Q2: 1,143,949 shares 1,143,949$1.58M27.53%0Timeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
FIBROGEN INCFIBROGEN INC195,707$60.6Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001843547-25-000009 base2025-08-12acceptance time not in the bulk data set